Written question asked by Paul Beresford (Conservative) on Monday, 27 March 2023, in the House of Commons. It was due for an answer on Wednesday, 29 March 2023. It was answered by Maria Caulfield (Conservative) on Monday, 3 April 2023 on behalf of the Department of Health and Social Care.

Respiratory Syncytial Virus: Vaccination

Question: To ask the Secretary of State for Health and Social Care, if he will make it his policy to work with respiratory syncytial virus (RSV) immunisation manufacturers to support the implementation of a universal immunisation programme for the prevention of RSV-related lower respiratory tract infections in infants, to reduce winter pressures on the NHS.

Answer: The Joint Committee on Vaccination and Immunisation (JCVI) provides the Government with advice on all immunisation programmes, including respiratory syncytial virus (RSV). The JCVI is actively reviewing evidence around available products and the potential for an expanded or universal RSV programme. Once the JCVI have concluded their review of evidence and any advice is made, the Department will work with manufacturers, alongside the UK Heath Security Agency and NHS England, to support the implementation of advice as soon as is practicable.

Secondary information

Type: Written question
Reference: 174168
Session: 2022-23
Subjects: Babies Drugs Manufacturing industries Procurement Vaccination Respiratory syncytial virus
Link: View this Written question on www.parliament.uk